GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q2M Biotech AG (HAM:QBI) » Definitions » Receivables Turnover

Q2M Biotech AG (HAM:QBI) Receivables Turnover : 0.00 (As of . 20)


View and export this data going back to 2011. Start your Free Trial

What is Q2M Biotech AG Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Q2M Biotech AG's Revenue for the three months ended in . 20 was €0.00 Mil. Q2M Biotech AG's average Accounts Receivable for the three months ended in . 20 was €0.00 Mil.


Q2M Biotech AG Receivables Turnover Historical Data

The historical data trend for Q2M Biotech AG's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q2M Biotech AG Receivables Turnover Chart

Q2M Biotech AG Annual Data
Trend
Receivables Turnover

Q2M Biotech AG Quarterly Data
Receivables Turnover

Competitive Comparison of Q2M Biotech AG's Receivables Turnover

For the Biotechnology subindustry, Q2M Biotech AG's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Q2M Biotech AG's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Q2M Biotech AG's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Q2M Biotech AG's Receivables Turnover falls into.



Q2M Biotech AG Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Q2M Biotech AG's Receivables Turnover for the fiscal year that ended in . 20 is calculated as

Receivables Turnover (A: . 20 )
=Revenue / Average Total Inventories
=Revenue (A: . 20 ) / ((Accounts Receivable (A: . 20 ) + Accounts Receivable (A: . 20 )) / count )
= / (( + ) / 1 )
= / 0
=N/A

Q2M Biotech AG's Receivables Turnover for the quarter that ended in . 20 is calculated as

Receivables Turnover (Q: . 20 )
=Revenue / Average Total Inventories
=Revenue (Q: . 20 ) / ((Accounts Receivable (Q: . 20 ) + Accounts Receivable (Q: . 20 )) / count )
= / (( + ) / 1 )
= / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Q2M Biotech AG  (HAM:QBI) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Q2M Biotech AG Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Q2M Biotech AG's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Q2M Biotech AG (HAM:QBI) Business Description

Traded in Other Exchanges
N/A
Address
Haeschenstrasse 17-19, Bremen, DEU
Website
Q2M Biotech AG is a biotechnology company that examines and explains genetic information. The Company is also involved in the creation, development and sale of products, systems and solutions in the biotechnology field.

Q2M Biotech AG (HAM:QBI) Headlines

No Headlines